Lazard Freres Gestion S.A.S. Has $61.22 Million Stock Position in Colgate-Palmolive Company $CL

Lazard Freres Gestion S.A.S. lifted its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 46.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 673,448 shares of the company’s stock after purchasing an additional 212,229 shares during the quarter. Colgate-Palmolive makes up about 1.5% of Lazard Freres Gestion S.A.S.’s holdings, making the stock its 21st biggest position. Lazard Freres Gestion S.A.S. owned approximately 0.08% of Colgate-Palmolive worth $61,216,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of CL. Brighton Jones LLC raised its stake in shares of Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after buying an additional 450 shares in the last quarter. GAMMA Investing LLC raised its stake in shares of Colgate-Palmolive by 14.2% in the 1st quarter. GAMMA Investing LLC now owns 11,797 shares of the company’s stock valued at $1,105,000 after buying an additional 1,468 shares in the last quarter. Continuum Advisory LLC raised its stake in shares of Colgate-Palmolive by 31.1% in the 1st quarter. Continuum Advisory LLC now owns 1,171 shares of the company’s stock valued at $110,000 after buying an additional 278 shares in the last quarter. Oppenheimer Asset Management Inc. raised its stake in shares of Colgate-Palmolive by 69.9% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 23,854 shares of the company’s stock valued at $2,235,000 after buying an additional 9,815 shares in the last quarter. Finally, Legacy Advisors LLC raised its stake in shares of Colgate-Palmolive by 24.3% in the 1st quarter. Legacy Advisors LLC now owns 3,371 shares of the company’s stock valued at $316,000 after buying an additional 659 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 1.7%

CL opened at $78.47 on Friday. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The stock has a market capitalization of $63.42 billion, a PE ratio of 22.04, a PEG ratio of 4.69 and a beta of 0.34. Colgate-Palmolive Company has a 1-year low of $76.68 and a 1-year high of $100.18. The firm has a 50-day moving average price of $81.47 and a two-hundred day moving average price of $87.01.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.03. The firm had revenue of $5.11 billion during the quarter, compared to analysts’ expectations of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company’s quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter last year, the company posted $0.91 EPS. As a group, equities analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be given a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 2.7%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.43%.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on CL shares. Deutsche Bank Aktiengesellschaft set a $86.00 target price on shares of Colgate-Palmolive in a research report on Friday, October 10th. UBS Group cut their price target on shares of Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Citigroup cut their price target on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating for the company in a report on Monday, August 4th. Wells Fargo & Company cut their price target on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a report on Thursday, September 25th. Finally, Morgan Stanley cut their price target on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a report on Monday, August 4th. Eight analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $91.50.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.